In our previous studies, this MAGL inhibitor has already shown anti-invasive and antiangiogenic effects in normoxic lung cancer cells in vitro as well as antimetastatic and tumor-regressive effects in mice subjected to A549 lung cancer metastasis and xenograft models, respectively [4,13]. Here, MGLL is linked to lung cancer.